$TEAM

LIU GENE sold $254K of TEAM

LIU GENE (Chief Accounting Officer) sold 1,552 shares of Atlassian Corp (TEAM) at an average of $163.95 ($162.38–$167.29, $0.25M total) across 7 trades over 2026-08-13 to 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · LIU GENE
Published Aug 17, 2026, 11:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 11:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TEAM
Neutral
high confidence
Mentioned
$TEAM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TEAMNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not introduce new company fundamentals.

02

Market read

Traders may note the insider sale size ($254k) and timing, but the 10b5-1 structure suggests limited informational content.

03

What to watch

The article provides only the sale details; it does not include any concurrent buys, company guidance, or operational developments that would make the transaction more informative.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-17 after-hours; reflects sales dated 2026-08-13 to 2026-08-14

Background

The article is a SEC Form 4 insider transaction for Atlassian (TEAM) by Chief Accounting Officer Liu Gene.

Company-level read

Ticker impact

$TEAMNeutralHigh confidence
Context

Atlassian Form 4 shows CFO Liu Gene sold $254,449 of TEAM shares across 7 trades under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited, with any impact confined to short-term sentiment rather than a sustained repricing.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicit 10b5-1 plan, indicating pre-scheduled selling rather than new negative information.

Market effects

Minimal; insider 10b5-1 selling does not signal sector-wide fundamentals.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still be interpreted by some traders as confidence erosion, especially if paired with other negative signals not present here.

Key entities

  • Atlassian Corp

    Subject of the Form 4 insider transaction; ticker TEAM.

  • Liu Gene

    Chief Accounting Officer who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TEAMMed

From Bank Back Offices to Power Grids, Frontier AI Labs Push Deeper Into the Enterprise

Anthropic and OpenAI, two private AI developers, announced new initiatives focused on enterprise sales. Anthropic released a low-cost AI model, launched a cybersecurity program, and committed $250M to new initiatives. OpenAI expanded its enterprise partnerships and reported $50B annualized revenue. Publicly traded companies like Atlassian (TEAM), Palo Alto Networks (PANW), Booz Allen (BAH), Accenture (ACN), and Barclays (BCS) are involved in these partnerships.

$TEAMMed

Why Atlassian (TEAM) Stock Is Down Today

Atlassian (TEAM) shares fell 4.6% after Meta launched its Enterprise Platform, increasing competition in business software. The decline coincided with a sector-wide drop due to rising 10-year Treasury yields. Atlassian's stock later recovered slightly, closing at $179.73, down 4.3%. The company's shares have been volatile, with a 16.1% gain year-to-date but a 53% loss over five years.

$TEAMMed

Enterprise Software Stocks Rally as Tech Tape Slides: Atlassian Corporation, Monday.com and Salesforce Climb 3%, ServiceNow Nudges Higher

Enterprise software stocks rose on Wednesday, with Atlassian (TEAM), Monday.com (MNDY), Salesforce (CRM), and ServiceNow (NOW) up 2-3%. Atlassian announced accelerated U.S. federal cloud investments. The iShares Expanded Tech-Software Sector ETF (IGV) gained 1% while the Invesco QQQ Trust (QQQ) fell 0.88%. Rising long-term Treasury yields typically pressure such stocks, making the rally unusual.

$TEAMMedAI 8/10

Atlassian Says AI Tailwind Is Building as Cloud Growth and Rovo Adoption Accelerate

Atlassian reported accelerated cloud revenue growth (31% YoY) in Q4, driven by customer expansion and cross-selling. The company highlighted the migration from Data Center to cloud as a multiyear opportunity, with customers spending 1.75x more post-migration. Atlassian also emphasized AI adoption, with Rovo AI seeing increased usage and driving higher ARR growth for customers. The company expects to achieve a 4.5% GAAP operating margin by fiscal 2027, balancing AI investments with profitability.